Manufacturer
KOTRA PHARMA (M) SDN. BHD.
Contents
Cinnarizine
Indication
Symptomatic treatment of nausea & vertigo due to Meniere's disease & other labyrinthine disturbances, prevention & treatment of motion sickness, management of various vascular disorders.
Instruction
Adult & childn >12 yr 1 tab tds. Motion sickness Adult & childn >12 yr 1 tab 2 hr before travelling followed by ½ tab 8 hrly, 5-12 yr ½ adult dose.
Drug interaction
Increased sedative effect w/ CNS depressants or TCAs.
Malaysia
